Hussein Zaitoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hussein Zaitoon has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Ellen Bamberger
Department of Pediatrics Bnai Zion Medical Center The Ruth and Bruce Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
2 shared publicationsIrina Chistyakov
Department of Pediatrics Bnai Zion Medical Center The Ruth and Bruce Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
2 shared publicationsIsaac Srugo
Department of Pediatrics Bnai Zion Medical Center The Ruth and Bruce Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
2 shared publicationsBracha Mendelson
Department of Clinical Microbiology, Bnai Zion Medical Center, Haifa, Israel
1 shared publicationLiat Yaniv
Department of Pediatrics, Bnai Zion Medical Center, Haifa, Israel
1 shared publicationLivnat Sharkansky
Department of Pediatrics Bnai Zion Medical Center The Ruth and Bruce Rappaport Faculty of Medicine Technion‐Israel Institute of Technology Haifa Israel
1 shared publication
Latest Publications
- Open Access
- 6 October 2021
- Published by Wiley in Public Health Nursing
- Vol. 39 (2) , 415-422
Evaluation of Israeli healthcare workers knowledge and attitudes toward the COVID‐19 vaccine
Objectives Healthcare workers (HCWs) are considered an important target group for the COVID-19 vaccines. The current study assesses the knowledge and attitudes of Israeli HCWs regarding COVID-19 immunization, and how various occupational and demographic factors may underlie COVID-related knowledge and attitudes differences. Methods Following a pre-test to validate measures, a cross-sectional online anonymous survey was distributed to HCWs using a snowball sampling method. Results The survey was completed by 714 participants (mean age 39.9; range 18–74; 447 female), 52% doctors, 32% nurses, and the remainder by paramedical staff. Of the respondents, 553 (77.4%) answered the question are you in favor of getting the COVID-19 vaccine, 105 (14.7%) were not sure, and 56 (7.8%) were not in favor. Doctors had higher odds of agreement as compared to both nurses (p < .025) and paramedical staff (p < .001). Multivariate logistic regression analysis revealed that increased age (OR: 1.075; 95% CI: 1.04–1.11, p < .001), profession (physician vs. nurse; OR: 2.73; 95% CI: 1.32–5.65; p < .007), and getting the current influenza vaccine (OR: 4.96; 95% CI: 2.47–9.95) were significant predictors of agreement. Conclusions A high level of HCWs knowledge and in favor attitudes were observed. Yet negative attitudes were also noted, particularly among nurses, paramedical staff, and young employees.
- 6 October 2021
- Published by Wiley in Public Health Nursing
- Vol. 39 (2) , 415-422
Open AccessEvaluation of Israeli healthcare workers knowledge and attitudes toward the COVID‐19 vaccine
Objectives Healthcare workers (HCWs) are considered an important target group for the COVID-19 vaccines. The current study assesses the knowledge and attitudes of Israeli HCWs regarding COVID-19 immunization, and how various occupational and demographic factors may underlie COVID-related knowledge and attitudes differences. Methods Following a pre-test to validate measures, a cross-sectional online anonymous survey was distributed to HCWs using a snowball sampling method. Results The survey was completed by 714 participants (mean age 39.9; range 18–74; 447 female), 52% doctors, 32% nurses, and the remainder by paramedical staff. Of the respondents, 553 (77.4%) answered the question are you in favor of getting the COVID-19 vaccine, 105 (14.7%) were not sure, and 56 (7.8%) were not in favor. Doctors had higher odds of agreement as compared to both nurses (p < .025) and paramedical staff (p < .001). Multivariate logistic regression analysis revealed that increased age (OR: 1.075; 95% CI: 1.04–1.11, p < .001), profession (physician vs. nurse; OR: 2.73; 95% CI: 1.32–5.65; p < .007), and getting the current influenza vaccine (OR: 4.96; 95% CI: 2.47–9.95) were significant predictors of agreement. Conclusions A high level of HCWs knowledge and in favor attitudes were observed. Yet negative attitudes were also noted, particularly among nurses, paramedical staff, and young employees.
- 1 February 2020
- Vol. 22 (2) , 71-74
A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital
Background: The introduction of pneumococcal conjugate vaccine-13 (PCV-13) has reduced the burden of invasive pneumococcal disease. Objectives: To characterize true positive blood cultures of children who presented to our hospital following implementation of the PCV-13 vaccine. Methods: A retrospective study was conducted on positive blood cultures of children presenting with fever from 2010-2017. Subjects were divided into two age groups: a younger group 3-36 months and an older group 3-18 years. Patients were classified as either having a focus of infection at the time of their bacteremia or not. Pneumococcal isolates were typed at Israel's Streptococcal Reference Laboratory. Results: The samples included 94 true positive blood cultures. Focal infection with concomitant bacteremia was more common than bacteremia without a focus both overall: 67/94 (71%) vs. 27/94 (28.7%), P < 0.001 as well as in the two groups: 32/48 (66%) vs. 16/48 (33%), P = 0.02 in the younger group and 35/46 (76%) vs. 11/46 (24%), P = 0.001 in the older group. Streptococcus pneumoniae was the most common pathogen overall, 27/94 (29%), and in the younger group, 21/48 (44%), but rare in the older group, 6/46 (13%). In the latter, Brucella species predominated, 12/46 (26%), along with Staphylococcus aureus 12/46 (26%). Conclusions: Our findings are consistent with other studies reporting decreased pneumococcal bacteremia, bacteremia primarily accompanying focal infection, and changing etiological agents among PCV-13-vaccinated children. Brucella species was prominent in older children with osteoarticular infections. Ongoing surveillance is warranted to better understand the implications of PCV-13.
- 1 February 2020
- Vol. 22 (2) , 71-74
A Retrospective Study of the Impact of Pneumococcal Conjugate Vaccine-13 Immunization in a Northern Israel Hospital
Background: The introduction of pneumococcal conjugate vaccine-13 (PCV-13) has reduced the burden of invasive pneumococcal disease. Objectives: To characterize true positive blood cultures of children who presented to our hospital following implementation of the PCV-13 vaccine. Methods: A retrospective study was conducted on positive blood cultures of children presenting with fever from 2010-2017. Subjects were divided into two age groups: a younger group 3-36 months and an older group 3-18 years. Patients were classified as either having a focus of infection at the time of their bacteremia or not. Pneumococcal isolates were typed at Israel's Streptococcal Reference Laboratory. Results: The samples included 94 true positive blood cultures. Focal infection with concomitant bacteremia was more common than bacteremia without a focus both overall: 67/94 (71%) vs. 27/94 (28.7%), P < 0.001 as well as in the two groups: 32/48 (66%) vs. 16/48 (33%), P = 0.02 in the younger group and 35/46 (76%) vs. 11/46 (24%), P = 0.001 in the older group. Streptococcus pneumoniae was the most common pathogen overall, 27/94 (29%), and in the younger group, 21/48 (44%), but rare in the older group, 6/46 (13%). In the latter, Brucella species predominated, 12/46 (26%), along with Staphylococcus aureus 12/46 (26%). Conclusions: Our findings are consistent with other studies reporting decreased pneumococcal bacteremia, bacteremia primarily accompanying focal infection, and changing etiological agents among PCV-13-vaccinated children. Brucella species was prominent in older children with osteoarticular infections. Ongoing surveillance is warranted to better understand the implications of PCV-13.